Is There a Place for Insulin Pump Therapy in Your Practice?
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
IN BRIEF Insulin pump therapy is becoming a preferred treatment modality of diabetes specialists for the management of patients with diabetes. As a result,internists, general practitioners, nurse practitioners, and allied health care professionals will more frequently encounter patients using, or desiring to use, these devices. This article serves as an introduction to the principles that guide patient selection, patient education of self-management skills, and the practical aspects of pump management that everyone assisting patients on pump therapy should be aware of.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus
The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.287.19.2563 · Cited by 941
Hypoglycaemia: the limiting factor in the glycaemic management of type I and type II diabetes.
Cryer, P. (2002) · Diabetologia · doi:10.1007/s00125-002-0822-9 · Cited by 794
Bode, B. W., Steed, R. D., & Davidson, P. C. (1996) · Diabetes Care · doi:10.2337/diacare.19.4.324 · Cited by 257
Bode, B., Weinstein, R., Bell, D., McGill, J., Nadeau, D., Raskin, P., Davidson, J., Henry, R., Huang, W.-C., & Reinhardt, R. R. (2002) · Diabetes Care · doi:10.2337/diacare.25.3.439 · Cited by 148
Raskin, P., Holcombe, J. H., Tamborlane, W. V., Malone, J. I., Strowig, S., Ahern, J. A., & Lavent, F. (2001) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(01)00168-4 · Cited by 71
Research works printed but not linked: 18
- Pickup J, Keen H:Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care 25: 593-598,2002 · DOI · Paper page
- The DCCT Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993 · DOI · Paper page
- Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B:Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353:2643-2653, 2005 · DOI · Paper page
- Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR:Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321:405-412, 2000 · DOI · Paper page
- The UKPDS Study Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837-853,1998 · DOI · Paper page
- Boland EA, Grey M,Oesterle A, Fredrickson L, Tamborlane WV: Continuous subcutaneous insulin infusion: a new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. Diabetes Care 22:1779-1784, 1999 · DOI · Paper page
- Jeha GS, Karaviti LP, Anderson B, Smith EO, Donaldson S, McGirk TS, Haymond MW: Insulin pump therapy in preschool children with type 1 diabetes mellitus improves glycemic control and decreases glucose excursions and the risk of hypoglycemia. Diabetes Technol Ther 7:876-884, 2005 · DOI · Paper page
- Kaufman FR,Halvorson M, Miller D, Mackenzie M, Fisher LK, Pitukcheewanont P: Insulin pump therapy in type 1 pediatric patients: now and into the year 2000. Diabetes Metab Res Rev 15:338-352, 1999 · DOI · Paper page
- Nielsen S, Kain D,Szudzik E, Dhindsa S, Garg R, Dandona P: Use of continuous subcutaneous insulin infusion pump in patients with type 2 diabetes mellitus. Diabetes Educ 31:843-848, 2005 · DOI
- Radermecker RP,Scheen AJ: Continuous subcutaneous insulin infusion with short-acting insulin analogues or human regular insulin: efficacy, safety, quality of life, and cost-effectiveness. Diabetes Metab Res Rev 20: 178-188,2004 · DOI
- Melki V, Renard E,Lassmann-Vague V, Boivin S, Guerci B, Hanaire-Broutin H, Bringer J, Belicar P,Jeandidier N, Meyer L, Blin P, Agendre-Ferrante B, Tauber JP: Improvement of HbA1c and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps. Diabetes Care 21: 977-982,1998 · DOI · Paper page
- Wainstein J,Metzger M, Boaz M, Minuchin O, Cohen Y, Yaffe A, Yerushalmy Y, Raz I,Harman-Boehm I: Insulin pump therapy vs. multiple daily injections in obese type 2 diabetic patients. Diabet Med 22: 1037-1046,2005 · DOI · Paper page
- Raskin P, Bode BW,Marks JB, Hirsch IB, Weinstein RL, McGill JB, Peterson GE, Mudaliar SR,Reinhardt RR: Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized,parallel-group, 24-week study. Diabetes Care 26: 2598-2603,2003 · DOI · Paper page
- Colquitt J, Royle P, Waugh N: Are analogue insulins better than soluble in continuous subcutaneous insulin infusion? Results of a meta-analysis. Diabet Med 20: 863-866,2003 · DOI · Paper page
- Renner R, Pfutzner A, Trautmann M, Harzer O, Sauter K, Landgraf R: Use of insulin lispro in continuous subcutaneous insulin infusion treatment: results of a multicenter trial. Diabetes Care 22:784-788, 1999 · DOI · Paper page
- Zinman B,Tildesley H, Chiasson JL, Tsui E, Strack T: Insulin lispro in CSII: results of a doubleblind crossover study. Diabetes 46: 440-443,1997 · DOI
- DeFelippis MR,Bell MA Heyob JA Storms SM: In vitro stability of insulin lispro in continuous subcutaneous insulin infusion. Diabetes Technol Ther 8: 358-368,2006 · DOI · Paper page
- Griffin ME, Feder A, Tamborlane WV: Lipoatrophy associated with lispro insulin in insulin pump therapy: an old complication, a new cause? Diabetes Care 24: 174,2001 · DOI
Cited by
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J., Dralle, H., Ebeling, P. R., Melmed, S., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,477
Cryer, P. E., Axelrod, L., Grossman, A. B., Heller, S. R., Montori, V. M., Seaquist, E. R., & Service, F. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1410 · Cited by 1,277
Francis, G. L., Waguespack, S. G., Bauer, A. J., Angelos, P., Benvenga, S., Cerutti, J. M., Dinauer, C. A., Hamilton, J., Hay, I. D., Luster, M., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0460 · Cited by 1,238
Insulin delivery methods: Past, present and future
Shah, R., Shah, V., Patel, M., & Maahs, D. (2016) · International Journal of Pharmaceutical Investigation · doi:10.4103/2230-973x.176456 · Cited by 287
Evolution of Insulin Delivery Devices: From Syringes, Pens, and Pumps to DIY Artificial Pancreas
Kesavadev, J., Saboo, B., Krishna, M. B., & Krishnan, G. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00831-z · Cited by 221
Metadata
- Authors
- Skyler, J. S., Ponder, S., Kruger, D. F., Matheson, D., & Parkin, C. G.
- Venue
- Clinical Diabetes
- Publisher
- American Diabetes Association
- Published
- 2007-04-01
- Volume
- 25
- Issue
- 2
- Pages
- 50-56
- ISSN
- 0891-8929 (ISSN-L)
- 1945-4953
- OpenAlex
- W2107370727
- Cited by
- 49
- References
- 5
- FWCI
- 2.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Is There a Place for Insulin Pump Therapy in Your Practice? https://app.cochat.ai/papers/10.2337/diaclin.25.2.50
- The paper
- Skyler, J. S., Ponder, S., Kruger, D. F., Matheson, D., & Parkin, C. G. (2007). Is There a Place for Insulin Pump Therapy in Your Practice? Clinical Diabetes. https://doi.org/10.2337/diaclin.25.2.50
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.